62 related articles for article (PubMed ID: 2630228)
21. [Determination of serum activity of glucose phosphate isomerase and glutathione reductase in intra and extra hepatic cholestasis.(author's transl)].
Tor J; Segura RM; Pascual C; Vilaseca J; Guarner ML; Schwartz S
Med Clin (Barc); 1981 Oct; 77(6):236-9. PubMed ID: 7321637
[TBL] [Abstract][Full Text] [Related]
22. Current problems with intrahepatic bile duct stones in Japan--congenital biliary malformations as a cause.
Fujii H; Yang Y; Matsumoto Y; Suda K
Hepatogastroenterology; 1997; 44(14):328-41. PubMed ID: 9164499
[TBL] [Abstract][Full Text] [Related]
23. Serum IgM-bound secretory component (sIgM) in liver diseases: comparative molecular state of the secretory component in serum and bile.
Delacroix DL; Jonard P; Dive C; Vaerman JP
J Immunol; 1982 Jul; 129(1):133-8. PubMed ID: 7086127
[TBL] [Abstract][Full Text] [Related]
24. Rapid decrease of secretory IgA serum levels in extrahepatic obstructive jaundice after surgical relief of the bile duct obstruction.
Cuadrado E; Arenas JI; Echaniz P; Garcia Gonzalez M; Damiano A
Gastroenterology; 1983 Jan; 84(1):203-4. PubMed ID: 6847851
[No Abstract] [Full Text] [Related]
25. Indicators of liver excretory function in patients undergoing biliary decompression for obstructive jaundice.
Chen CY; Shiesh SC; Lin XZ
Hepatogastroenterology; 1998; 45(21):786-90. PubMed ID: 9684135
[TBL] [Abstract][Full Text] [Related]
26. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis.
Summerfield JA; Kirk AP; Chitranukroh A; Billing BH
Hepatogastroenterology; 1981 Jun; 28(3):139-42. PubMed ID: 7250892
[TBL] [Abstract][Full Text] [Related]
27. The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets.
Chen CY; Shiesh SC; Wu MC; Lin XZ
Am J Gastroenterol; 1999 Sep; 94(9):2408-11. PubMed ID: 10484000
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 6 in bile as an indicator of liver function after hepatectomy in patients with biliary tract carcinoma.
Maeda A; Nagino M; Takeuchi E; Sano T; Kurumiya Y; Nimura Y
Br J Surg; 1999 Apr; 86(4):458-64. PubMed ID: 10215814
[TBL] [Abstract][Full Text] [Related]
29. Biochemical epidemiology of gallbladder cancer.
Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
[TBL] [Abstract][Full Text] [Related]
30. Serum endothelin-1 and hepatocyte growth factor levels in patients with obstructive jaundice.
Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Tsukamoto T; Tanaka H; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 1999; 46(27):1599-602. PubMed ID: 10430302
[TBL] [Abstract][Full Text] [Related]
31. High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component.
Delacroix DL; Reynaert M; Pauwels S; Geubel AP; Vaerman JP
Dig Dis Sci; 1982 Apr; 27(4):333-40. PubMed ID: 7067586
[TBL] [Abstract][Full Text] [Related]
32. Serum secretory component: a potential marker of biliary obstruction.
Farris MA; Chandy KG; Ashdown K; Elias E; Burnett D
Clin Chim Acta; 1983 Sep; 133(1):65-73. PubMed ID: 6627677
[TBL] [Abstract][Full Text] [Related]
33. Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease.
Kvale D; Schrumpf E; Brandtzaeg P; Solberg HE; Fausa O; Elgjo K
J Hepatol; 1987 Apr; 4(2):229-35. PubMed ID: 3584932
[TBL] [Abstract][Full Text] [Related]
34. [Circulating immune complexes in the blood serum of patients with liver and biliary tract pathology manifesting as a jaundice syndrome].
Podil'chak MD; Terletskaia LM; Podil'chak EM; Mats'kiv KA
Klin Khir (1962); 1985; (9):28-9. PubMed ID: 4057808
[No Abstract] [Full Text] [Related]
35. [Immunologic study of cholelithiasis and chronic biliary inflammation: determination of biliary and serum immunoglobulins and immunoglobulin-secreting cell density in the biliary tract].
Yang Y; Yang KZ; Huang ZQ
Zhonghua Nei Ke Za Zhi; 1985 Sep; 24(9):536-9, 573-4. PubMed ID: 4085306
[No Abstract] [Full Text] [Related]
36. [Cellular immunity in obstructive jaundice of cholelithic etiology].
Masalin MM; Zelentsova OA; Orazbekov NI
Klin Khir (1962); 1984 Sep; (9):15-8. PubMed ID: 6333546
[No Abstract] [Full Text] [Related]
37. Single stranded DNA binding antibodies in patients with obstructive jaundice.
Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
Jpn J Surg; 1985 Mar; 15(2):118-22. PubMed ID: 4010092
[TBL] [Abstract][Full Text] [Related]
38. [Free amino acid level and proteins in blood serum in patients with disorders of extrahepatic bile tract].
Dudenko GI; Dotsenko GD; Bagdasarian TV
Klin Khir (1962); 1978 Oct; (10):30-4. PubMed ID: 713299
[No Abstract] [Full Text] [Related]
39. Secretory immunoglobulin A in hepatobiliary diseases.
Vuitton DA; Seillès E; Cozon G; Rossel M; Bresson-Hadni S; Revillard JP
Dig Dis; 1991; 9(2):78-91. PubMed ID: 2036735
[No Abstract] [Full Text] [Related]
40. [Formation of secretory immunoglobin by the hepatic clearance mechanism].
Somos S; Schmidt A; Loibl A; Gróf P
Nahrung; 1984; 28(6-7):695-8. PubMed ID: 6493328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
